These findings are clinically grounded in the studied HIV population, but they should not be presented as proof that tesamorelin increases muscle size, athletic performance, or strength in healthy adults
(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Nevertheless, secondary analyses and observational data have sparked interest
Research comparing the gut microbiome in children with and without PWS is ongoing
2014 Feb 25;82(8):665-70
Compounding pharmacies may face restrictions similar to what happened with compounded semaglutide when Ozempic faced shortage declarations and subsequent regulatory scrutiny